Journal of Chest Surgery

  • 제36권11호
  • /
  • Pages.799-811
  • /
  • 2003
  • /
  • 2765-1606(pISSN)
  • /
  • 2765-1614(eISSN)
대한심장혈관흉부외과학회 (The Korean Society for Thoracic and Cardiovascular Surgery)
권호 표지

흰쥐의 적출심장에서 HTK 심정지액과 DelNido 심정지액의 심근보호효과비교

Comparison of Cardioprotection between Histidine-Tryptophan-Ketoglutarate Cardioplegia and DelNido Cardioplegia in Isolated Rat Hearts

  • 공준혁 (경북대학교 의과대학 흉부외과학교실) ;
  • 김대현 (경북대학교 의과대학 흉부외과학교실) ;
  • 장봉현 (경북대학교 의과대학 흉부외과학교실)
  • 발행 : 2003.11.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

배경: 본 연구에서는 심정지액 중 비교적 최근에 임상에 소개된 HTK 심정지액과 DelNido 심정지액의 심근보호효과를 비교하고자 하였다. 이를 위하여 적출 쥐의 심장을 사용한 동물실험을 통하여 혈류역학적 심기능검사, 생화학적 대사물질검사 및 심근미세구조의 변화를 비교 관찰하여 그 성적을 보고하는 바이다. 대상 및 방법: 심정지액 투여방법을 기준으로 흰쥐 수컷 79마리를 세 군으로 나누어서 실험하였다. 제1군(28마리)에서는 DelNido 심정지액을 1차 주입 후 40분 간격으로 2차, 3차 주입을 하였고, 제2군(27마리)에서는 HTK 심정지액을 1차례만 주입하였으며, 제3군(24마리)에서는 HTK 심정지액을 DeINido 심정지액과 같은 방법으로 3차례 주입하였다. 혈류역학적 심기능검사로 심박동수, 좌심실내압, 심근수축력(+dp/dt max), 분당 관 관류량 및 심부담값을 각 군에서 허혈전과 재관류후 15분, 30분 및 45분에 측정하여 비교하였다. 생화학적 대사물질검사로는 aspartate aminotransferase (AST), lactate dehydrogenase (LD), creatine kinase (CK), creatine kinase-MB (CK-MB), troponin-I, myoglobin, lactate를 허혈 전과 재관류 45분 후에 관 관류액을 취하여 측정하였다. 심근미세구조검사는 혈류역학적 심기능검사에서 비교적 중간값을 보인 실험 3예에서 재관류 45분 후 심첨부에서 좌심실 심근의 일부를 생검하여 전자현미경으로 관찰하였다. 결과: 혈류역학적 심기능검사상 재관류 후 좌심실 내압, 분당 관 관류량, 심부담값의 감소율 비교 시 통계학적 유의성은 없었으나, 재관류 후 심박동수의 감소율이 대조군(제1군)보다 실험군(제2군과 제3군)에서 유의하게 낮았다. 생화학적 대사물질 검사상 재관류 후 AST, LD, CK, CK-MB, troponin-I, myoglobin의 증가율 비교 시 통계학적 유의성은 없었으나, 재관류 후 lactate치의 증가율이 대조군보다 실험군에서 유의하게 낮았다 심근미세구조검사상 제1군, 제2군, 제3군에서 사립체 점수는 2.14$\pm$0.10, 1.52$\pm$0.57, 2.10$\pm$0.16으로 관찰되었다. 결론: 이상의 흰쥐의 적출심장을 이용한 실험결과를 종합해보면, 심근보호측면에서 정질성 심정지액인 HTK용액은, 혈성 심정지액인 DelNido용액과 비교 시, 혈류역학적 심기능검사상 심박동수의 감소율에서 그리고 생화학적 대사물질검사상 lactate의 증가율에서 우수한 성적을 보였다.

Background: The aim of this study is to define the cardioprotective effects (hemodynamic, cytochemical and ultrastructural of the newly developed Histidine-Tryptophan-Ketoglutarate (HTK) cardioplegia compared to DelNido cardioplegia. Material and Method: Seventy-nine isolated rat hearts were divided into three groups on the basis of techniques of cardioplegia infusion. Twenty-eight hearts (Group 1) were flushed with cold DelNido cardioplegia with every 40 minutes for 2 hours. Twenty-seven hearts (Group 2) were flushed with cold HTK cardioplegia for once during the 2 hours. Twenty-four hearts (Group 3) were flushed with cold HTK cardioplegia with every 40 minutes for 2 hours. Heart rate, left ventricular developed pressure (LVDP), changes of + dp/dt max, coronary flow, and rate-pressure product value were measured at pre-ischemic, post-reperfusion 15 minutes, 30 minutes, and 45 minutes for hemodynamic study. Aspartate aminotransferase (AST), lactate dehydrogenase (LD), creatine kinase (CK), CK-MB, troponin-I, myoglobin, and lactate were measured at pre-ischemic and post-reperfusion 45 minutes for cytochemical parameters. Mitochondrial scores were counted in 3 cases from each group for ultrastructural assessment. Result: In hemodynamic study, there were no significant differences among group 1, group 2, and group 3. However, the decrease values of heart rate in group 2 and 3 exhibited significantly lower values than in group 1. In cytochemical study, there were no significant differences among group 1, group 2, and group 3. However, the increase values of lactate in group 2 and 3 exhibited significantly lower values than in group 1. In ultrastructural assessment, the mean myocardial mitochondria scores in group 1, group 2, and group 3 were 2.14$\pm$0.10, 1.52$\pm$0.57, and 2.10$\pm$0.16. Conclusion: HTK solution provides adequate myocardial protection with some advantages over DelNido solution in isolated rat hearts.

키워드

참고문헌

  1. J Thorac Cardiovasc Surg v.77 A proprosed solution to the cardioplegic controversy Buckberg,G.D.
  2. Circulation v.76 no.supplⅤ The effect of cardioplegic oxygenation on the correlation between the linearized Frank-Starling relationship and myocardial energetics in the ejecting post-ischemic heart Krukenkamp,I.B.;Silverman,N.A.;Levitsky,S.
  3. J Thorac Cardiovasc Surg v.95 The effect of temperature and hematocrit level of oxygenated cardioplegic solutions on myocardial preservation Rousou,J.A.;Engleman,R.M.;Breyer,R.H.(et al.)
  4. Ann Thorac Surg v.47 Post-operative conduction disturbances: a comparison of blood and crystalloid cardioplegia Gundry,S.R.;Sequeira,A.;Coughlin,T.R.;McLaughlin,J.S. https://doi.org/10.1016/0003-4975(89)90378-0
  5. Ann Surg v.132 General hypothermia for experimental intracardiac surgery Bigelow,W.G.;Callanghan,J.C.;Hopps,J.A. https://doi.org/10.1097/00000658-195009000-00018
  6. Surgery v.33 Closure of atrial septal defects with the aid of hypothermia: experimental accomplishments and the report of one successful case Lewis,F.J.;Taufic,M.
  7. Minn Med v.37 Application of a mechanical heart and lung apparatus to cardiac surgery Gibbon,J.H.Jr.
  8. Lancet v.2 Elective cardiac arrest: preliminary communication Melrose,D.G.;Dryer,B.;Bentall,H.H.;Becker,J.B.E.
  9. Arch Surg Forum v.77 Potassium, magnesium and neostigmine for controlled cardioplegia Sealy,W.C.;Young,W.G.Jr;Brown,I.(et al.) https://doi.org/10.1001/archsurg.1958.01290010035007
  10. Verh Dtsch Ges Kreislaufforschung v.30 Uberlebenszeit und Weiderbelebungszeit des Herzens bei Normo- und Hypothermie Bretschneider,H.J.
  11. Circulation v.54 Cellular protection during myocardial ischemia: the development and characterization of a procedure for the induction of reversible ischemic arrest Hearse,D.F.;Stewart,D.A.;Braimbridge,M.V. https://doi.org/10.1161/01.CIR.54.2.193
  12. Advances in clinical cardiology v.1 Optimization of myocardial protection Bretschneider,H.J.;Gebhard,M.M.;Preusse,C.J.;Heiss,E.W.(ed.);G.Witstrock
  13. J Card Surg v.13 Comparison of clinical outcome between histidine-tryptophan-ketoglutarate solution and cold blood cardioplegic solution in mitral valve replacement Jun-ichi,S.;Kiyofumi,M.;Toshiro,I.;Tokuo,K.;Teruhisa,K.;Tomio,A. https://doi.org/10.1111/j.1540-8191.1998.tb01053.x
  14. J Thorac Cardiovasc Surg v.93 The relative buffering power of cardioplegic solutions Kresh,J.Y.;Nastala,C.;Bianchi,C.(et al.)
  15. J Thorac Cardiovasc Surg v.89 The role of cardioplegic solution buffering in myocardial protection. A biochemical and histopathological assessment Del NidoP.J.;Wilson,G.J.;Mickle,D.A.(et al.)
  16. Cardiovasc Res v.22 Role of red blood cells in the coronary microcirculation during cold blood cardioplegia Sakai,A.;Miya;Sohara,Y.(et al.) https://doi.org/10.1093/cvr/22.1.62
  17. Int J Cardiol v.62 no.sup.1 Cardioprotective efficacy of ischemic preconditioning on long-term myocardial ischemia Lu,H.;Hachida,M.;Ohkado,A.(et al.)
  18. Cardiovasc Res v.27 Improved functional recovery by ischemic preconditioning is not mediated by adenosine in the globally ischemic isolated rat heart Cave,A.C.;Collins,C.S.;Downey,J.M.;Hearse,D.J. https://doi.org/10.1093/cvr/27.4.663
  19. Korean J Thorac Cardiovasc Surg v.31 no.6 Comparative analysis of α-STAT and pH-STAT strategies during deep hypothermic circulatory arrest in the young pig Kim,W.G.;Lim,C.;Moon,H.J.;Won,T.H.;Kim,Y.J.
  20. Korean J Thorac Cardiovasc Surg v.33 no.8 Evaluation of cardioprotective effects of DelNido cardioplegia Woo,S.J.;Chang,B.H.;Kim,K.T.
  21. J Thorac Cardiovasc Surg v.98 The predictive value of serum enzymes for perioperative myocardial infarction after cardiac operations Fredrick,V.L.;Amy,M.;Norman,B.(et al.)
  22. Clin Chem v.32 Creatine kinase isoenzymes in extracts of various human skeletal muscles Tsung,J.S.;Tsung,S.S.
  23. Ann Thorac Surg v.69 Troponin levels in patients with myocardial infarction after coronary artery bypass grafting Michel,C.;Mischel,P.;Louis,P.(et al.) https://doi.org/10.1016/S0003-4975(99)01294-1
  24. J Thorac Cardiovasc Surg v.92 Studies of controlled reperfusion after ischemia, I. When is cardaic muscle damaged irreversibly? Buckberg,G.D.
  25. J Thorac Cardiovasc Surg v.95 Reperfusion injury after temporary coronary occlusion Viten-Johansan,J.;Johnson,W.E.;Millis,S.A.(et al.)
  26. Circulation v.51~52 no.sup.1 Histochemical and structural changes in human myocardial cells after cardiopulmonary bypass Bittar,N.;Koke,J.R.;Berkoff,H.A.;Kahs,D.R.
  27. J Thorac Cardiovasc Surg v.92 Ultrastructural study comparing the efficary of five different methods of intraoperative myocardial protection in the human heart Schaper,J.;Scheld,H.H.;Schmidt,U.(et al.)
  28. J Moll Cell Cardiol v.9 Ultrastructural alterations during ischemia and reperfusion in human hearts during cardiac surgery Schaper,J.;Hehrlein,F.;schlepper,M.(et al.) https://doi.org/10.1016/0022-2828(77)90028-1
  29. Eur J Cardiovasc Surg v.2 no.4 Energy state of the myocardium during long-term cold storage and subsequent reperfusion Schaper,J.;Hehrlein,F.;schlepper,M.(et al.) https://doi.org/10.1016/1010-7940(88)90079-6
  30. Korean J Thorac Cardiovasc Surg v.33 no.9 Changes of myocardial ultra-structure during open heart surgery Hur,J.;Kong,J.H.;Lee,J.T.